Age: two years and eight months | |||||
---|---|---|---|---|---|
Hematological Parameter | Reference range | ||||
Hemoglobin level | 5.6 g/dl | 11.1–16.3 g/dl | |||
Total Leucocyte Count | 142 x 103 cells/µl | 4–10 x 103 cells/µl | |||
Neutrophils | 87% (124 x 103 cells / µl) | 40–80% (2–7 x 103 cells/µl) | |||
Lymphocytes | 10% (14.2x103 cells / µl) | 20–40% (1–3 x 103 cells/µl) | |||
Monocytes | 0 | 2–10% (0.2-1x 103 cells/µl) | |||
Eosinophils | 1% (1.4x103 cells / µl) | 1–6% (0.02–0.5 x 103 cells/µl) | |||
Platelets | 94 x 103 cells / µl | 150-410x 103 cells/µl | |||
Peripheral film: | hypochromic, anisocytosis, leukocytosis with neutrophilia | Normochromic and normocytic | |||
Blood group: | O positive | Â | |||
Immunological Work-up | Reference range | ||||
Serum Immunoglobulins (Ig): | Â | Â | |||
IgG | 9.5 | 2.3 to 14.1 g/l | |||
IgA | 0.9 | 0-0.83 g/l | |||
IgM | 1.5 | 0-1.45 g/l | |||
IgE | 476 | < 100 IU/ml | |||
Complements (C) | Â | Â | |||
C3 | 0.8 | 0.8–1.73 g/l | |||
C4 | 0.19 | 0.13–0.47 g/l | |||
Lymphocyte subset analysis: | % Ratio | Cells/µl | % Ratio | Cells/µl | |
Total CD3+ T cells | 57 | 8580 | 57 to 81 | 1000 to 4900 | |
CD3+CD4+ (helper) T cells | 36.7 | 5580 | 24 to 47 | 500 to 2700 | |
CD3+CD8+ (cytotoxic) T cells | 17.5 | 2670 | 17 to 37 | 300 to 2100 | |
CD16+56+ (NK1) cells | 10.1 | 1540 | 8 to 28 | 200 to 900 | |
CD 19+ (B) cells | 31.4 | 4780 | 10 to 27 | 200 to 2200 | |
Flow cytometric analysis for CD11/CD18 | expression of CD11c, and CD18 were less than 1% on the patient’s neutrophils, while expression of CD11b was 74% | ||||
Other tests: | Â | Â | |||
C-reactive Protein-H (CRP-H) | 35 mg/dl | < 05 mg/dl | |||
Anti-HIV2-IgG | Negative | Negative | |||
Anti-HCV3-IgG | Negative | Negative | |||
Mutation analysis for beta 2 integrin gene | A homozygous splice-site variant (c.994–1G > C) was detected in the patient. |